Andrea Giuffrida, PhD
Andrea Giuffrida, Ph.D. is the Vice President for Research at UT Health San Antonio®, and a full professor in the Department of Pharmacology in the Joe R. and Teresa Lozano Long School of Medicine. He oversees the institutional research infrastructure and operations, regulatory compliances, and academia-industry partnerships. He also serves as liaison to The University of Texas System for matters related to research advocacy and technology commercialization.
Dr. Giuffrida has provided important breakthroughs to the neuropharmacology of the cannabinoid system, which have been published in high-impact journals, including Nature and Nature Neuroscience. His research focuses on the role played by endocannabinoids in psychomotor disorders characterized by dopaminergic dysfunction, such as schizophrenia and Parkinson’s disease. Dr. Giuffrida served as an AAAS Science & Technology Policy Fellow in the Office of Science Policy at the National Institutes of Health, and he is actively engaged in life science and biotechnology networks in the state, the U.S. and internationally. He is also a member of the editorial boards of the International Journal of Neuropsychopharmacology and Pharmaceutical Regulatory Affairs,
He currently serves on the board of directors of BioMed SA and Texas Health and Bioscience Institute, whose mission is promoting the development of bioscience and healthcare in the state. In addition, Dr. Giuffrida serves on the boards of trustees of the Texas Research & Technology Foundation and the Texas Biomedical Research Institute, and on the Executive Leadership Group of the Association of Academic Health Centers, an international organization promoting biomedical research and the education of the next generation of health professionals.